On Sept. 23, the House Energy and Commerce Health Subcommittee held a hearing on “Examining the Increase in Drug Shortages.” Among those testifying before the Congressional panel were members of the Drug Shortage Summit Legislative and Regulatory Work Group, a group of stakeholders initially brought together in Nov. 2010 and currently functioning as an informal coalition to advance drug shortage solutions.
On Sept. 26, the FDA held a public workshop on drug shortages. ASA physicians and staff worked closely with the FDA on the program for the meeting, which included a report on the impact of drug shortages on anesthesiologists and patients.
Related Articles on Anesthesia:
74% of Michigan Residents Understand What Anesthesiologists Do
Researchers Map Molecular Pathways Used by Common Pain Drug
Dr. Michael Humphrey Discusses Draw, Downsides of Anesthesiology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
